• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jcellbiolHomeThe Rockefeller University PressEditorsContactInstructions for AuthorsThis issue
J Cell Biol. Oct 2, 1992; 119(2): 349–355.
PMCID: PMC2289650

The EGF receptor is an actin-binding protein

Abstract

In a number of recent studies it has been shown that in vivo part of the EGF receptor (EGFR) population is associated to the actin filament system. In this paper we demonstrate that the purified EGFR can be cosedimented with purified filamentous actin (F-actin) indicating a direct association between EGFR and actin. A truncated EGFR, previously shown not to be associated to the cytoskeleton, was used as a control and this receptor did not cosediment with actin filaments. Determination of the actin-binding domain of the EGFR was done by measuring competition of either a polyclonal antibody or synthetic peptides on EGFR cosedimentation with F-actin. A synthetic peptide was made homologous to amino acid residues 984-996 (HL-33) of the EGFR which shows high homology with the actin-binding domain of Acanthamoeba profilin. A polyclonal antibody raised against HL-33 was found to prevent cosedimentation of EGFR with F-actin. This peptide HL-33 was shown to bind directly to actin in contrast with a synthetic peptide homologous to residues 1001-1013 (HL-34). During cosedimentation, HL-33 competed for actin binding of the EGFR and HL-34 did not, indicating that the EGFR contains one actin-binding site. These results demonstrate that the EGFR is an actin-binding protein which binds to actin via a domain containing amino acids residues 984-996.

Full Text

The Full Text of this article is available as a PDF (1.1M).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Akiyama T, Kadowaki T, Nishida E, Kadooka T, Ogawara H, Fukami Y, Sakai H, Takaku F, Kasuga M. Substrate specificities of tyrosine-specific protein kinases toward cytoskeletal proteins in vitro. J Biol Chem. 1986 Nov 5;261(31):14797–14803. [PubMed]
  • Bellot F, Moolenaar W, Kris R, Mirakhur B, Verlaan I, Ullrich A, Schlessinger J, Felder S. High-affinity epidermal growth factor binding is specifically reduced by a monoclonal antibody, and appears necessary for early responses. J Cell Biol. 1990 Feb;110(2):491–502. [PMC free article] [PubMed]
  • Berkers JA, van Bergen en Henegouwen PM, Boonstra J. Three classes of epidermal growth factor receptors on HeLa cells. J Biol Chem. 1991 Jan 15;266(2):922–927. [PubMed]
  • Boonstra J, Mummery CL, van der Saag PT, de Laat SW. Two receptor classes for epidermal growth factor on pheochromocytoma cells, distinguishable by temperature, lectins, and tumor promoters. J Cell Physiol. 1985 Jun;123(3):347–352. [PubMed]
  • Bretscher A. Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor. J Cell Biol. 1989 Mar;108(3):921–930. [PMC free article] [PubMed]
  • Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem. 1987;56:881–914. [PubMed]
  • Carpentier JL, Rees AR, Gregoriou M, Kris R, Schlessinger J, Orci L. Subcellular distribution of the external and internal domains of the EGF receptor in A-431 cells. Exp Cell Res. 1986 Oct;166(2):312–326. [PubMed]
  • Carraway KL, Carraway CA. Membrane-cytoskeleton interactions in animal cells. Biochim Biophys Acta. 1989 May 9;988(2):147–171. [PubMed]
  • Comens PG, Simmer RL, Baker JB. Direct linkage of 125I-EGF to cell surface receptors. A useful artifact of chloramine-T treatment. J Biol Chem. 1982 Jan 10;257(1):42–45. [PubMed]
  • Defize LH, Boonstra J, Meisenhelder J, Kruijer W, Tertoolen LG, Tilly BC, Hunter T, van Bergen en Henegouwen PM, Moolenaar WH, de Laat SW. Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors. J Cell Biol. 1989 Nov;109(5):2495–2507. [PMC free article] [PubMed]
  • Fava RA, Cohen S. Isolation of a calcium-dependent 35-kilodalton substrate for the epidermal growth factor receptor/kinase from A-431 cells. J Biol Chem. 1984 Feb 25;259(4):2636–2645. [PubMed]
  • Hartwig JH, Stossel TP. Isolation and properties of actin, myosin, and a new actinbinding protein in rabbit alveolar macrophages. J Biol Chem. 1975 Jul 25;250(14):5696–5705. [PubMed]
  • Honegger AM, Dull TJ, Felder S, Van Obberghen E, Bellot F, Szapary D, Schmidt A, Ullrich A, Schlessinger J. Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing. Cell. 1987 Oct 23;51(2):199–209. [PubMed]
  • Hunter T, Cooper JA. Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cells. Cell. 1981 Jun;24(3):741–752. [PubMed]
  • Hunter T, Cooper JA. Protein-tyrosine kinases. Annu Rev Biochem. 1985;54:897–930. [PubMed]
  • Ito M, Tanabe F, Sato A, Ishida E, Takami Y, Shigeta S. Possible involvement of microfilaments in protein kinase C translocation. Biochem Biophys Res Commun. 1989 May 15;160(3):1344–1349. [PubMed]
  • King AC, Cuatrecasas P. Resolution of high and low affinity epidermal growth factor receptors. Inhibition of high affinity component by low temperature, cycloheximide, and phorbol esters. J Biol Chem. 1982 Mar 25;257(6):3053–3060. [PubMed]
  • King CS, Cooper JA. Effects of protein kinase C activation after epidermal growth factor binding on epidermal growth factor receptor phosphorylation. J Biol Chem. 1986 Aug 5;261(22):10073–10078. [PubMed]
  • Lassing I, Lindberg U. Specific interaction between phosphatidylinositol 4,5-bisphosphate and profilactin. Nature. 1985 Apr 4;314(6010):472–474. [PubMed]
  • Lichtner RB, Schirrmacher V. Cellular distribution and biological activity of epidermal growth factor receptors in A431 cells are influenced by cell-cell contact. J Cell Physiol. 1990 Aug;144(2):303–312. [PubMed]
  • Moolenaar WH, Bierman AJ, Tilly BC, Verlaan I, Defize LH, Honegger AM, Ullrich A, Schlessinger J. A point mutation at the ATP-binding site of the EGF-receptor abolishes signal transduction. EMBO J. 1988 Mar;7(3):707–710. [PMC free article] [PubMed]
  • Payrastre B, Plantavid M, Breton M, Chambaz E, Chap H. Relationship between phosphoinositide kinase activities and protein tyrosine phosphorylation in plasma membranes from A431 cells. Biochem J. 1990 Dec 15;272(3):665–670. [PMC free article] [PubMed]
  • Payrastre B, van Bergen en Henegouwen PM, Breton M, den Hartigh JC, Plantavid M, Verkleij AJ, Boonstra J. Phosphoinositide kinase, diacylglycerol kinase, and phospholipase C activities associated to the cytoskeleton: effect of epidermal growth factor. J Cell Biol. 1991 Oct;115(1):121–128. [PMC free article] [PubMed]
  • Pollard TD, Cooper JA. Actin and actin-binding proteins. A critical evaluation of mechanisms and functions. Annu Rev Biochem. 1986;55:987–1035. [PubMed]
  • Prywes R, Livneh E, Ullrich A, Schlessinger J. Mutations in the cytoplasmic domain of EGF receptor affect EGF binding and receptor internalization. EMBO J. 1986 Sep;5(9):2179–2190. [PMC free article] [PubMed]
  • Rebillard M, Leibovitch S, Jullien M, Talha S, Harel L. Early stimulation by EGF plus insulin of rRNA, c-fos, and actin mRNA expression: inhibition by cytochalasin D. Exp Cell Res. 1987 Oct;172(2):432–438. [PubMed]
  • Rijken PJ, Hage WJ, van Bergen en Henegouwen PM, Verkleij AJ, Boonstra J. Epidermal growth factor induces rapid reorganization of the actin microfilament system in human A431 cells. J Cell Sci. 1991 Nov;100(Pt 3):491–499. [PubMed]
  • Roy LM, Gittinger CK, Landreth GE. Epidermal growth factor treatment of A431 cells alters the binding capacity and electrophoretic mobility of the cytoskeletally associated epidermal growth factor receptor. J Cell Physiol. 1991 Jan;146(1):63–72. [PubMed]
  • Schlessinger J. The epidermal growth factor receptor as a multifunctional allosteric protein. Biochemistry. 1988 May 3;27(9):3119–3123. [PubMed]
  • Spaargaren M, Defize LH, Boonstra J, de Laat SW. Antibody-induced dimerization activates the epidermal growth factor receptor tyrosine kinase. J Biol Chem. 1991 Jan 25;266(3):1733–1739. [PubMed]
  • Tellam RL, Morton DJ, Clarke FM. A common theme in the amino acid sequences of actin and many actin-binding proteins? Trends Biochem Sci. 1989 Apr;14(4):130–133. [PubMed]
  • Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature. 309(5967):418–425. [PubMed]
  • Vale RD, Shooter EM. Conversion of nerve growth factor-receptor complexes to a slowly dissociating, Triton X-100 insoluble state by anti nerve growth factor antibodies. Biochemistry. 1983 Oct 11;22(21):5022–5028. [PubMed]
  • van Belzen N, Spaargaren M, Verkleij AJ, Boonstra J. Interaction of epidermal growth factor receptors with the cytoskeleton is related to receptor clustering. J Cell Physiol. 1990 Nov;145(2):365–375. [PubMed]
  • van Belzen N, Rijken PJ, Verkleij AJ, Boonstra J. Sulfhydryl reagents alter epidermal growth factor receptor affinity and association with the cytoskeleton. J Recept Res. 1991;11(6):919–940. [PubMed]
  • van Bergen en Henegouwen PM, Defize LH, de Kroon J, van Damme H, Verkleij AJ, Boonstra J. Ligand-induced association of epidermal growth factor receptor to the cytoskeleton of A431 cells. J Cell Biochem. 1989 Apr;39(4):455–465. [PubMed]
  • van Bergen en Henegouwen PM, den Hartigh JC, Romeyn P, Verkleij AJ, Boonstra J. The epidermal growth factor receptor is associated with actin filaments. Exp Cell Res. 1992 Mar;199(1):90–97. [PubMed]
  • Vandekerckhove JS, Kaiser DA, Pollard TD. Acanthamoeba actin and profilin can be cross-linked between glutamic acid 364 of actin and lysine 115 of profilin. J Cell Biol. 1989 Aug;109(2):619–626. [PMC free article] [PubMed]
  • Walker DH, Pike LJ. Phosphatidylinositol kinase is activated in membranes derived from cells treated with epidermal growth factor. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7513–7517. [PMC free article] [PubMed]
  • Wiegant FA, Blok FJ, Defize LH, Linnemans WA, Verkley AJ, Boonstra J. Epidermal growth factor receptors associated to cytoskeletal elements of epidermoid carcinoma (A431) cells. J Cell Biol. 1986 Jul;103(1):87–94. [PMC free article] [PubMed]
  • Yarden Y, Schlessinger J. Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry. 1987 Mar 10;26(5):1434–1442. [PubMed]
  • Yonezawa N, Nishida E, Iida K, Yahara I, Sakai H. Inhibition of the interactions of cofilin, destrin, and deoxyribonuclease I with actin by phosphoinositides. J Biol Chem. 1990 May 25;265(15):8382–8386. [PubMed]
  • Zechel K. Isolation of polymerization-competent cytoplasmic actin by affinity chromatography on immobilized DNAse I using formamide as eluant. Eur J Biochem. 1980 Sep;110(2):343–348. [PubMed]
  • Zippel R, Morello L, Brambilla R, Comoglio PM, Alberghina L, Sturani E. Inhibition of phosphotyrosine phosphatases reveals candidate substrates of the PDGF receptor kinase. Eur J Cell Biol. 1989 Dec;50(2):428–434. [PubMed]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...